DOP75 Loss-of-response and immunogenicity following immunomodulator withdrawal from anti-tumour necrosis factor alpha combination therapy: Results from a large retrospective cohort study
Remi Mahmoud(University Medical Center Utrecht), Bas Oldenburg(University Medical Center Utrecht), B van Hellemondt(Utrecht University), P van Boeckel(St. Antonius Ziekenhuis), J Schultheiss(University Medical Center Utrecht), Nofel Mahmmod(St. Antonius Ziekenhuis), Bindia Jharap(Meander Medisch Centrum), Mariëlle van der Kaaij(University Medical Center Utrecht), Herma H. Fidder(University Medical Center Utrecht), J Louwers(University Medical Center Utrecht)
Cited by 0
Related Papers
Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
|Clinical and Translational Gastroenterology|2016|724
Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial
|The Lancet Oncology|2011|470
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252